Bladder Cancer | Jonathan E Rosenberg, MD

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #4: Current and Future Role of Recently Approved Novel Therapies in the Management of Urothelial Bladder Carcinoma — Dr Rosenberg CME information and select publications